Briefly, after treatment with TGF-β1 in the absence or presence of hesperetin for 48 hour, MDA-MB-231 cells were collected in a RIPA buffer (Wako, Japan) added with protein inhibitors by using a cell scraper. The proteins were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to polyvinylidene fluoride membranes. The membranes were blocked using 5% non-fat milk solution, then were treated with primary antibodies at 4°C overnight. Next, the membranes were washed 3 times in TBS-T and incubated with secondary antibodies for 1 hour at room temperature. Finally, Super Signal West Pico chemiluminescence substrates (Thermo Fisher Scientific, Waltham USA) were used to visualize the stained proteins. The protein bands were evaluated using Quantity One with ChemuDoc XRS-J software (Bio-Rad, USA).
Western Blot Analysis of TGF-β1 and Hesperetin Effects
Briefly, after treatment with TGF-β1 in the absence or presence of hesperetin for 48 hour, MDA-MB-231 cells were collected in a RIPA buffer (Wako, Japan) added with protein inhibitors by using a cell scraper. The proteins were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to polyvinylidene fluoride membranes. The membranes were blocked using 5% non-fat milk solution, then were treated with primary antibodies at 4°C overnight. Next, the membranes were washed 3 times in TBS-T and incubated with secondary antibodies for 1 hour at room temperature. Finally, Super Signal West Pico chemiluminescence substrates (Thermo Fisher Scientific, Waltham USA) were used to visualize the stained proteins. The protein bands were evaluated using Quantity One with ChemuDoc XRS-J software (Bio-Rad, USA).
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Jilin Medical University
Variable analysis
- Treatment with TGF-β1
- Treatment with hesperetin
- Protein expression levels
- Absence of TGF-β1 and hesperetin treatment
- Positive control: Cells treated with TGF-β1
- Negative control: Cells without any treatment
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!